# Azora Therapeutics, Inc. (DE): Form 8-K, filed Oct 16, 2026

- Company: [Azora Therapeutics, Inc. (DE)](/companies/adil.md) (CIK 1513525)
- Form: 8-K
- Filed: 2026-10-16
- Accepted by EDGAR: Oct 16, 2026, 17:15 ET
- Period: 2026-10-15
- Accession: 0001213900-26-110349
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1513525/000121390026110349/ea0308909-8k_adial.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1513525/000121390026110349/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1513525/000121390026110349/ea0308909-8k_adial.htm

Filed Oct 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-110349. Last ingested by Listed: Nov 10, 2026, 17:05 ET. No prices; not investment advice.